Search
for
Sort by
Research 811–840 of 1000+
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Deoxycholic acid in the submental fat reduction: A review of properties, adverse effects, and complications
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
- Bexxar, iodine I 131 tositumomab, Effective in Long Term Follow-up of Non-Hodgkin's Lymphoma
- Fractional CO₂ laser combined with topical compound betamethasone for Vitiligo-Associated Leukotrichia: a retrospective study of 13 patients with limited effectiveness
- A Split Scalp Study of Single versus Double Spin Platelet-rich plasma Injections in Treatment of Female Pattern Hair Loss: Clinical Effect and Relation to Vascular Endothelial Growth Factor in PRP
- Structural optimization of pep7, a small peptide extracted from epimorphin, for effective induction of hair follicle anagen
- Discovery of New Drug Therapies Based on the Study of Adverse Reactions
- Antihelminthic Drugs
- Dermatological Drugs, Topical Agents, and Cosmetics
- Cytostatics and immunosuppressive drugs
- Sex hormones and related compounds, including hormonal contraceptives
- Dermatological drugs and topical agents
- Minoxidil in severe hypertension with renal failure
- Treatment of Severe Hypertension with Minoxidil: Advantages and Limitations
- Essential Oils and Their Single Compounds in Cosmetics—A Critical Review
- Dermatological adverse events with taxane chemotherapy
- Minoxidil: a review of its pharmacological properties and therapeutic use.
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Hypertrichosis induced by latanoprost
- Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity
- Minoxidil in refractory hypertension
- Systemic treatment for alopecia areata
- Patch Testing in Allergic Contact Dermatitis from Minoxidil
- Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors
- Minoxidil-induced hypertrichosis: Pathophysiology, clinical implications, and therapeutic strategies
- Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia
- Chemotherapy and Cutaneous Drug Reactions
- Complications of Mesotherapy
- Pramipexole